Summary
This prediction ended on 03.02.17 with a price of €103.45. The SELL prediction by mohabbatein finished with a performance of 20.07%. mohabbatein has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -3.121% | -3.121% | 114.565% | -20.696% |
| iShares Core DAX® | -0.559% | 0.738% | 14.807% | 57.558% |
| iShares Nasdaq 100 | -0.566% | -0.324% | 3.991% | 86.023% |
| iShares Nikkei 225® | 1.073% | 5.624% | 19.546% | 49.340% |
| iShares S&P 500 | 0.868% | 0.030% | 1.475% | 58.072% |
Comments by mohabbatein for this prediction
In the thread Bayer AG diskutieren
mohabbatein stimmt dem Crowdsentiment von 'Buy' nicht zu
mohabbatein stimmt am 30.05.2016 dem Buy-Crowdsentiment mit dem Kursziel 111.26€ nicht zu.
Sollte, wie allseits bereits gemunkelt wird, Bayer sein Gebot für Monsanto zeitnah von 122,- auf 130,- Dollar erhöhen, wird der Kurs nochmals in die Knie gehen.
SELL, bis mehr Klarheit vorhanden ist.